OXYGEN THERAPY

[kimblanchard]

Hi friends,

Do any of you know anything about Oxygen Therapy for cancer? A friend sent me this suggestion saying it was the best way to deal with Bill's disease instead of drugs. I did a search on the internet and came up with a ton of sites to support it but don't know if this is just another thing to cloud our judgement and decision making. For example - here is one site:

http://www.thenutritiondoctor.com/the_l ... xygen.html

Let me know what you think if you have time to look at any of this.

Blessings to you,

Peg

[john]

Peg,

Here is a counter argument.

http://www.quackwatch.org/01QuackeryRel ... oxygen.htm

Here is another way to think about this. Many endurance athletes like mile runners, marathon runners, cyclists, do their training anaerobiclly (without oxygen). This happens when they can not take in enough oxygen to support the demands of the running or exercise.

Typically, lactic acid buildup occurs and runners feel sore the next day.

If the theory that lack of oxygen causes cancer, then there should be more cancer in mile runners, etc.

I doubt this is the case. In fact they are probably healthy overall than the general population

God bless and take care. Good luck with the Iressa. It does seem to work in a number of people

John

[john]

Another drug related to oxygen and cancer. Maybe there is something to O2 and cancer

Tirapazamine: Some individuals with cancer have lower than normal oxygen concentrations (called hypoxia) in the body tissues and in some of the cancer cells. Cancer cells that have low oxygen levels often become resistant to radiation therapy and chemotherapy drugs, making the disease more difficult to treat. Tirapazamine is a drug that is not active against cells with normal oxygen concentrations, but kills cells that are poorly oxygenated. Because this process results in the elimination of the cancer cells that are resistant to treatment, it is believed that the use of tirapazamine with standard anti-cancer chemotherapy drugs and/or radiation therapy may be effective.

Researchers from several hospitals in the United States and Europe conducted a clinical study to determine the effectiveness of Platinol® with tirapazamine in patients with advanced or metastatic NSCLC. A total of 446 patients were assigned to receive either Platinol® alone or Platinol® with tirapazamine. The response rate was almost 28% in patients receiving Platinol® and tirapazamine, compared with 14% in patients receiving Platinol® alone. The average survival time was almost 35 weeks in patients receiving tirapazamine and 28 weeks in those receiving Platinol® alone.

The researchers concluded that tirapazamine enhances the activity of Platinol® in patients with advanced or metastatic NSCLC. Since the most active drugs against NSCLC include platinum compounds, paclitaxel, Taxotere® and Gemzar®, future clinical studies will likely evaluate the effectiveness of combination chemotherapy regimens in combination with tirapazamine. Patients with metastatic NSCLC may wish to talk with their doctor about the risks and benefits of participating in clinical trials evaluating chemotherapy with tirapazamine or participating in other clinical trials in which promising new treatments are being studied.

http://www.411cancer.com/treat.html